Harun Ozalp | Anadolu | Getty ImagesThe free version of ChatGPT may provide inaccurate or incomplete responses — or no answer at all — to questions related to medications, which could potentially endanger patients who use OpenAI's viral chatbot, a...
A newly inaugurated alliance of top scientists from six global institutions, including the University of Hong Kong (HKU), will prioritise studying influenza and coronaviruses as part of efforts to prepare for the next potential pandemic.Pandemic Research Alliance founding members professors...
The Hong Kong Jockey Club has partnered with the century-old Rockefeller Foundation to bolster public health across the globe and protect some of the most vulnerable people from the impacts of climate change.The racing and gambling operator’s new Institute of...
By Xinqi Su, Yan Zhao and Holmes Chan Unlike her fellow Hong Kong urbanites toting plastic or paper cups filled with coffee, pet groomer Lucine Mo takes her caffeine hit in a thermal mug with a QR code. The coded...
SHENZHEN, China - China's surge in respiratory illness is caused by known pathogens and there is no sign of new infectious diseases, a health official said on Saturday (Dec 2) as the country faces its first full winter since lifting...
An 83-year-old patient has died after tubing from a blood pressure machine was found wrapped around his neck at a Hong Kong hospital in a suspected suicide.Hong Kong Buddhist Hospital, which has reported the case to police, on Saturday evening...
Sopa Images | Lightrocket | Getty ImagesPfizer's twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences. The drugmaker on Friday said it...
By Rebecca Bailey in Shanghai, China A year after historic protests broke out on Shanghai’s bustling Wulumuqi Road, only a subtly increased police presence on main junctions betrays anything out of the ordinary. Increased police presence is seen around the junction...
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost significant weight but had trouble tolerating the drug in a mid-stage clinical study. The drugmaker observed high...
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that's good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday...
